|
|
Other links at Articles > Business of Medicine |
| 1. |
Celgene Wins US Approval to Expand Vidaza Label
|
|
|
Celgene Corp said on Thursday that U.S. regulators have given it the green light to add information to the label of its drug Vidaza showing it prolonged life in some patients with myelodysplastic syndromes, or MDS, a group of blood disorders that can lead to leukemia. Reuters Health Information
|
| 3. |
Group Sues US in Push for New Antibiotic Warning
|
|
|
A consumer group asked a U.S. court on Thursday to force regulators to decide if stronger warnings should be added to certain antibiotics to alert doctors and patients about the risks of tendon rupture. Reuters Health Information
|
|
|